InvestorsHub Logo
icon url

Tadasana

11/17/16 10:02 AM

#83654 RE: Rising_Sun #83619

Agreed, UMC Johannes Gutenberg Germany Knows DCVax L works!
icon url

iclight

11/17/16 10:31 AM

#83665 RE: Rising_Sun #83619

Linda Powers, CEO of NW Bio, noted that, "More than 2 years of planning and work have gone into developing this Phase II trial program.



Guess they knew the blinded trial results two years ago, when they submitted this contract for translation (thanks koman).
icon url

slappdaddy

11/17/16 10:59 AM

#83681 RE: Rising_Sun #83619

If DCVax-L Phase 3 is a failure, why would anyone wasting time and money to develop further with such a failed drug? They know something more that we know.



Your response to this question is exactly why they would start another trial without releasing the results of the L trial. To keep the trials going consecutively in order to never have to release results. This could go on for another decade except for the fact that the funding will eventually dry up and then BANKRUPTCY for NWBO and business as usual for Cognate.